Skip to content

README.md

Latest commit

 

History

History
20 lines (12 loc) · 1.42 KB

README.md

File metadata and controls

20 lines (12 loc) · 1.42 KB
Raw

Paroxetine-Alprazolam-DDI

Modeling of published paroxetine-alprazolam-DDI studies for model evaluation

Repository files

Within this repository, we distribute a PK-Sim snapshot containing simulations of all published clinical studies used to evaluate the predictive performance of the paroxetine and alprazolam models regarding paroxetine-alprazolam-DDIs, including the respective observed data digitized from literature reports. The applied paroxetine model has been published previously [1].

For further details and documentation please refer to [2].

Version information

OSP Version 11.0

License

The model is distributed under the GPLv2 Lincense.

Reference

[1] Rüdesheim, S.; Selzer, D.; Mürdter, T.; Igel, S.; Kerb, R.; Schwab, M.; Lehr, T. Physiologically Based Pharmacokinetic Modeling to Describe the CYP2D6 Activity Score-Dependent Metabolism of Paroxetine, Atomoxetine and Risperidone. Pharmaceutics 2022, 14, 1734.

[2] Rüdesheim S, Loer HLH, Feick D, Marok FZ, Fuhr LM, Selzer D, Teutonico, D, Schneider ARP, Solodenko J, Frechen S, vdL Maaike, Moes DJAR, Swen JJ, Schwab M, Lehr T. A Comprehensive CYP2D6 Drug-Drug-Gene Interaction Network for Application in Precision Dosing and Drug Development. Clin Pharmacol Ther. 2025, doi: 10.1002/cpt.3604.